The wholesale industry’s problems have been building for some time. From McKesson’s earnings call, I have interpreted some of its most revealing statements, which illuminate the key challenges facing wholesalers:
- Why wholesalers want brand-name drug prices to go up—and the negative impact of slowing inflation
- A sell-side price war started by...AmerisourceBergen?
- The factors pressuring wholesalers' profits from specialty pharmacies